Gsottberger, F., Meier, C., Ammon, A., Parker, S., Wendland, K., George, R., … Mueller, F. (2022). Targeted Inhibition of Protein Biosynthesis sensitizes Cancer Cells to IRE1a-mediated Apoptosis as a Consequence of the unfolded protein response. In ONCOLOGY RESEARCH AND TREATMENT (Vol. 45, pp. 161–161).

Gsottberger, F., C. Meier, A. Ammon, S. Parker, K. Wendland, R. George, S. Petkovic, et al. “Targeted Inhibition of Protein Biosynthesis sensitizes Cancer Cells to IRE1a-mediated Apoptosis as a Consequence of the unfolded protein response.” In ONCOLOGY RESEARCH AND TREATMENT, 45:161–161, 2022.

Gsottberger F, Meier C, Ammon A, Parker S, Wendland K, George R, et al. Targeted Inhibition of Protein Biosynthesis sensitizes Cancer Cells to IRE1a-mediated Apoptosis as a Consequence of the unfolded protein response. In: ONCOLOGY RESEARCH AND TREATMENT. 2022. p. 161–161.

Gsottberger, F., et al. “Targeted Inhibition of Protein Biosynthesis sensitizes Cancer Cells to IRE1a-mediated Apoptosis as a Consequence of the unfolded protein response.” ONCOLOGY RESEARCH AND TREATMENT, vol. 45, no. SUPPL 2, 2022, pp. 161–161.

Gsottberger F, Meier C, Ammon A, Parker S, Wendland K, George R, Petkovic S, Mellenthin L, Emmerich C, Lutzny-Geier G, Mackensen A, Metzler M, Chandramohan V, Mueller F. Targeted Inhibition of Protein Biosynthesis sensitizes Cancer Cells to IRE1a-mediated Apoptosis as a Consequence of the unfolded protein response. ONCOLOGY RESEARCH AND TREATMENT. 2022. p. 161–161.